Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Uncontrolled, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074 (Vixotrigine) in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

NCT02957617 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02957617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02957617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Uncontrolled, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074 (Vixotrigine) in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy
Lead sponsor
Biogen
Phase
Phase 2
Overall status
Terminated
Start date
February 10, 2017
Completion date
February 7, 2019
Enrollment
302 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathic pain from lumbosacral radiculopathy